Skip to main content

Table 3 Comparison of clinical and CSF characteristics in VPSV and VPSWOV patients within 1 week after the operation

From: Ventriculoperitoneal shunts in non-HIV cryptococcal meningitis

  

VPSV (n = 13)

VPSWOV (n = 10)

P 1

P 2

P

symptoms improved

headache

10/11(90.1%)

10/10(100%)

0.001

<0.001

>0.999

Visual

4/7(57.1%)

5/7(71.4%)

>0.999

0.153

>0.999

Auditory

1/2(50%)

0/3

0.371

0.07

0.40

Mental change

4/5(80%)

2/3(66.7%)

0.615

0.510

0.464

CSF

CSF pressure (mmH2O) median (range)

153(55–330)

180(95–330)

<0.001

<0.001

0.402

 

WBC count (×106/l) median (range)

70(2–459)

80(25–232)

0.42

0.018

0.868

 

Protein, g/L median (range)

1.43(0.3–7.7)

1.61(0.51–3.98)

<0.001

<0.001

0.334

 

Glucose(mmol/l) median (range)

1.7(0.03–3.54)

1.17(0.43–7.45)

0.008

0.026

0.526

 

Chloride(mmol/l) median (range)

117(103–126)

116(103–126)

0.285

0.020

0.96

 

India ink Cryptococcus count

0(0–480)

3.12E2(0–3.01E4)

0.014

0.337

0.003

  1. P1 pre-operation versus within 1 week post operation in the VPSV group
  2. P2 pre-operation versus within 1 week post operation in the VPSWOV group
  3. P VPSV versus VPSWOV within 1 week post operation